Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZOTA HEALTH CARE vs TRANS ASIA CORP - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZOTA HEALTH CARE TRANS ASIA CORP ZOTA HEALTH CARE/
TRANS ASIA CORP		  
P/E (TTM) x -63.1 -0.3 - View Chart
P/BV x 20.9 0.3 7,532.2% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 ZOTA HEALTH CARE   TRANS ASIA CORP
EQUITY SHARE DATA
    ZOTA HEALTH CARE
Mar-25		 TRANS ASIA CORP
Mar-20		 ZOTA HEALTH CARE/
TRANS ASIA CORP		 5-Yr Chart
Click to enlarge
High Rs1,0783 31,612.9%   
Low Rs4403 13,583.3%   
Sales per share (Unadj.) Rs102.10-  
Earnings per share (Unadj.) Rs-19.8-0.2 12,587.3%  
Cash flow per share (Unadj.) Rs-4.7-0.2 3,004.5%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs78.111.5 677.3%  
Shares outstanding (eoy) m28.645.21 549.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.40-  
Avg P/E ratio x-38.3-21.1 181.9%  
P/CF ratio (eoy) x-160.5-21.1 762.2%  
Price / Book Value ratio x9.70.3 3,370.9%  
Dividend payout %-5.00-   
Avg Mkt Cap Rs m21,73517 125,493.1%   
No. of employees `000NANA-   
Total wages/salary Rs m8360 464,322.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,9240-  
Other income Rs m240-   
Total revenues Rs m2,9480-   
Gross profit Rs m-61-1 7,507.4%  
Depreciation Rs m4320-   
Interest Rs m1080 1,078,300.0%   
Profit before tax Rs m-576-1 70,297.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-90-   
Profit after tax Rs m-567-1 69,193.9%  
Gross profit margin %-2.10- 
Effective tax rate %1.60-   
Net profit margin %-19.40- 
BALANCE SHEET DATA
Current assets Rs m1,84219 9,911.8%   
Current liabilities Rs m1,0067 13,596.5%   
Net working cap to sales %28.60- 
Current ratio x1.82.5 72.9%  
Inventory Days Days680- 
Debtors Days Days5060- 
Net fixed assets Rs m2,46349 5,023.0%   
Share capital Rs m28652 549.7%   
"Free" reserves Rs m1,9518 24,411.8%   
Net worth Rs m2,23760 3,723.1%   
Long term debt Rs m500-   
Total assets Rs m4,30568 6,366.3%  
Interest coverage x-4.3-81.0 5.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70-   
Return on assets %-10.7-1.2 889.4%  
Return on equity %-25.4-1.4 1,850.1%  
Return on capital %-20.5-1.4 1,516.9%  
Exports to sales %9.70-  
Imports to sales %00-  
Exports (fob) Rs m283NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2830-   
Fx outflow Rs m80-   
Net fx Rs m2760-   
CASH FLOW
From Operations Rs m-5007 -7,524.7%  
From Investments Rs m-922-7 13,883.4%  
From Financial Activity Rs m1,448NA-  
Net Cashflow Rs m260-  

Share Holding

Indian Promoters % 49.4 12.5 395.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 14.6 0.0 -  
FIIs % 8.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.6 87.5 57.8%  
Shareholders   14,005 1,207 1,160.3%  
Pledged promoter(s) holding % 0.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZOTA HEALTH CARE With:   ADANI ENTERPRISES    REDINGTON    SYMPHONY    MMTC    CONFIDENCE PETROLEUM    


More on ZOTA HEALTH CARE vs TRANS ASIA CORP

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ZOTA HEALTH CARE vs TRANS ASIA CORP Share Price Performance

Period ZOTA HEALTH CARE TRANS ASIA CORP S&P BSE HEALTHCARE
1-Day -1.48% -4.76% -1.25%
1-Month 10.52% -24.88% 5.82%
1-Year 11.61% -29.05% 9.65%
3-Year CAGR 50.87% -2.10% 23.48%
5-Year CAGR 40.21% -4.97% 13.57%

* Compound Annual Growth Rate

Here are more details on the ZOTA HEALTH CARE share price and the TRANS ASIA CORP share price.

Moving on to shareholding structures...

The promoters of ZOTA HEALTH CARE hold a 49.4% stake in the company. In case of TRANS ASIA CORP the stake stands at 12.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ZOTA HEALTH CARE and the shareholding pattern of TRANS ASIA CORP.

Finally, a word on dividends...

In the most recent financial year, ZOTA HEALTH CARE paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of -5.0%.

TRANS ASIA CORP paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ZOTA HEALTH CARE, and the dividend history of TRANS ASIA CORP.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 964 Points | Nifty Above 24,300 | Kotak Mahindra & TCS Top Gainers Sensex Today Rallies 964 Points | Nifty Above 24,300 | Kotak Mahindra & TCS Top Gainers(Closing)

Although the benchmark indices opened higher, they traded positive throughout the session and ultimately closed green.

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Quantum Information Services Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

  • Registered Name:

    Quantum Information Services Private Limited

  • Registered Office Address:

    103, Regent Chambers, Nariman Point, Mumbai 400021

  • CIN:

    U65990MH1989PTC054667

  • Website:

    www.equitymaster.com

  • Compliance Officer & Grievance Officer:

    Ms. Sonal Ramachandran

    | Telephone No.: +91-22-61434003 | Email: compliance@equitymaster.com

SEBI Registered Research Analyst Details:

SEBI Registration No.: INH000021128 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 6769

Principal Officer: Tanushree Banerjee | Telephone No.:+91-22-61434055 | Email: po.ra@equitymaster.com

SEBI Registered Investment Adviser Details:

SEBI Registration No.: INA000000680 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 1488

Principal Officer: Vivek Chaurasia | Telephone No.:+91-22-61434055 | Email: po.ria@equitymaster.com

SEBI Office Details:

SEBI Bhavan BKC
Address: Plot No.C4-A, 'G' Block Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra
Telephone No.: +91-22-26449000 / 40459000 | Fax: +91-22-26449019-22 / 40459019-22 | Email: sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575
SCORES: https://www.scores.gov.in/ | SMARTODR: https://smartodr.in/login

Association of Mutual Funds of India (AMFI) Registered Details:

AMFI Registered Mutual Fund Distributor
AMFI Registration Number : ARN - 1022
Date of Initial Registration : 28 / JAN / 2008
Current Validity of ARN upto : 28 / JAN / 2028

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, enlistment with BSE as IA and RA, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing any content from this website whether wholly or in part, for any purpose without the permission of Quantum Information Services Private Limited is strictly prohibited and shall be deemed to be copyright infringement.

Quantum Information Services Private Limited (QIS) is a SEBI registered Research Analyst (bearing registration no INH000021128) and Investment Adviser(Reg. No: INA000000680). Consequent upon the merger of Equitymaster Research Private Limited into QIS, effective October 30, 2025 QIS owns and operates brand 'Equitymaster' and website www.equitymaster.com. This does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities and QIS including its employees, personnel, directors, associates will not be liable for any losses (direct or indirect) incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. All content and information is provided on an 'As Is' basis by QIS. Information herein is believed to be reliable but QIS does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by QIS are on a best effort basis. QIS does not assure or guarantee the user any minimum or fixed returns. The securities quoted, if any are for illustration only and are not recommendatory. Use of this information is at the user's own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject QIS or its affiliates to any registration or licensing requirement.

The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing QIS's content and website, you agree to our Terms and Conditions of Use, available here.